
Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell.
Photo Credit: The University of Queensland
Scientific Frontline: Extended "At a Glance" Summary: Blood-Based Proteomic Profiling for Non-Small Cell Lung Cancer
The Core Concept: A novel diagnostic blood test that analyzes thousands of proteins to predict how patients with non-small cell lung cancer (NSCLC) will respond to treatments like immunotherapy before therapy begins.
Key Distinction/Mechanism: Unlike traditional, highly invasive tissue biopsies, this method utilizes advanced protein measurement and statistical modeling on standard blood samples to identify biological signals directly linked to treatment response and potential disease relapse.
Major Frameworks/Components:
- Proteomic Analysis: The measurement of thousands of distinct proteins within a patient's blood sample.
- Statistical Modeling: The application of computational algorithms to translate complex protein data into predictive clinical signals.
- Longitudinal Tracking: The assessment of blood samples taken both before and after surgery and immunotherapy to monitor how protein levels fluctuate over time.
- Non-Small Cell Lung Cancer (NSCLC) Pathology: Focused research on the most common and deadly form of lung cancer.












.jpg)
.png)